Merck price target lowered to $110 from $125 at Wells Fargo
The Fly

Merck price target lowered to $110 from $125 at Wells Fargo

Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Merck (MRK) to $110 from $125 and keeps an Equal Weight rating on the shares. Merck’s Gardasil expectation reset is a step in right direction, but new investment would still need a narrative shift and Winrevair may not be enough to drive that, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App